- Home
- RFIL vs PASG Comparison
RFIL vs PASG Comparison
Compare RFIL & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFIL
- PASG
- Stock Information
- Founded
- RFIL 1979
- PASG 2017
- Country
- RFIL United States
- PASG United States
- Employees
- RFIL N/A
- PASG N/A
- Industry
- RFIL Electrical Products
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- RFIL Technology
- PASG Health Care
- Exchange
- RFIL Nasdaq
- PASG Nasdaq
- Market Cap
- RFIL 39.9M
- PASG 42.2M
- IPO Year
- RFIL N/A
- PASG 2020
- Fundamental
- Price
- RFIL $4.15
- PASG $0.60
- Analyst Decision
- RFIL Strong Buy
- PASG Strong Buy
- Analyst Count
- RFIL 1
- PASG 3
- Target Price
- RFIL $4.50
- PASG $8.00
- AVG Volume (30 Days)
- RFIL 21.1K
- PASG 886.7K
- Earning Date
- RFIL 01-16-2025
- PASG 03-03-2025
- Dividend Yield
- RFIL N/A
- PASG N/A
- EPS Growth
- RFIL N/A
- PASG N/A
- EPS
- RFIL N/A
- PASG N/A
- Revenue
- RFIL $64,857,000.00
- PASG N/A
- Revenue This Year
- RFIL N/A
- PASG N/A
- Revenue Next Year
- RFIL $8.38
- PASG N/A
- P/E Ratio
- RFIL N/A
- PASG N/A
- Revenue Growth
- RFIL N/A
- PASG N/A
- 52 Week Low
- RFIL $2.84
- PASG $0.45
- 52 Week High
- RFIL $4.65
- PASG $1.79
- Technical
- Relative Strength Index (RSI)
- RFIL 54.47
- PASG 43.68
- Support Level
- RFIL $3.80
- PASG $0.56
- Resistance Level
- RFIL $4.60
- PASG $0.64
- Average True Range (ATR)
- RFIL 0.21
- PASG 0.11
- MACD
- RFIL 0.06
- PASG -0.01
- Stochastic Oscillator
- RFIL 46.43
- PASG 8.69
About RFIL RF Industries Ltd.
RF Industries Ltd is engaged in the design, manufacture, and marketing of interconnect products and systems, including coaxial and specialty cables, fiber optic cables and connectors, and electrical and electronic specialty cables. The company operates through two segments: RF Connector and Cable Assembly, which consists of the Connector and Cable Assembly Division, and Custom Cabling Manufacturing and Assembly, which consists of its subsidiaries. The company has operations in the United States, Canada, Israel, and Mexico.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.